Solitaire FR device for treatment of dural sinus thrombosis.
Publication/Presentation Date
12-19-2012
Abstract
Dural venous sinus thrombosis is a rare and potentially devastating disease. Several predisposing factors exist, including oral contraceptive therapy and colitis. First-line therapy consists of systemic anticoagulation. If first-line therapies fail, more aggressive endovascular therapies may be performed. We report our initial experience with the Solitaire FR device for treatment of refractory symptomatic dural venous sinus thrombosis.
Volume
2012
ISSN
1757-790X
Published In/Presented At
Pukenas, B. A., Kumar, M., Stiefel, M., Smith, M., & Hurst, R. (2012). Solitaire FR device for treatment of dural sinus thrombosis. BMJ case reports, 2012, bcr2012010543. https://doi.org/10.1136/bcr-2012-010543
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
23257943
Department(s)
Administration and Leadership
Document Type
Article